Hims & Hers Health shares surge 39% on partnership with Novo Nordisk to distribute Wegovy obesity treatment, ending legal disputes over compounded drug sales while securing official distribution channel and eliminating regulatory uncertainties for the telehealth platform
#YonhapInfomax #HimsAndHers #NovoNordisk #Wegovy #ObesityTreatment #TelehealthPartnership #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=109028
'From Foes to Allies' - Hims & Hers Stock Soars on Novo Nordisk Partnership
Hims & Hers Health shares surge 39% on partnership with Novo Nordisk to distribute Wegovy obesity treatment, ending legal disputes over compounded drug sales while securing official distribution channel and eliminating regulatory uncertainties for the telehealth platform
Hims & Hers shares plunged over 16% after Novo Nordisk sued the telehealth firm for allegedly selling unauthorized generic versions of obesity drug Wegovy, intensifying legal risks in the US obesity drug market.
#YonhapInfomax #HimsAndHers #NovoNordisk #Wegovy #PatentInfringement #SharePriceDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=104655Hims & Hers Health Inc. has abandoned its plan to launch a generic version of Novo Nordisk's Wegovy after legal threats from both the FDA and Novo Nordisk, causing its shares to plunge 15.86% in after-hours trading.
#YonhapInfomax #HimsAndHers #Wegovy #NovoNordisk #FDA #Semaglutide #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=104489
Under Pressure from FDA and Novo Nordisk—Hims & Hers Abandons Plans to Launch Wegovy Generic
Hims & Hers Health Inc. has abandoned its plan to launch a generic version of Novo Nordisk's Wegovy after legal threats from both the FDA and Novo Nordisk, causing its shares to plunge 15.86% in after-hours trading.
Hims & Hers Health Inc. is acquiring European telemedicine platform Zava, expanding its reach across Europe and boosting its subscriber base by 50%, with shares rising over 7% pre-market.
#YonhapInfomax #HimsAndHers #Zava #Telemedicine #Acquisition #SubscriberGrowth #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=66015
Hims & Hers Acquires European Telehealth Platform Zava—Shares Surge 7% Pre-Market
Hims & Hers Health Inc. is acquiring European telemedicine platform Zava, expanding its reach across Europe and boosting its subscriber base by 50%, with shares rising over 7% pre-market.
Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and medication delivery for several beauty and lifestyle concerns, putting the tech giant in direct competition with Hims & Hers. Read more at
@Techcrunch.
#Amazon #AmazonOneMedical #Telehealth #HimsandHers #Tech #Technology https://flip.it/Dv6.YU
Amazon's telehealth platform adds low-cost plans for hair loss, skin care, and more | TechCrunch
Amazon One Medical is expanding its telehealth services with the launch of treatment plans and medication delivery for several beauty and lifestyle concerns.
Yonhap Infomax News
Flipboard Tech Desk